Ajooni Biotech Ltd
Incorporated in 2010, Ajooni Biotech Ltd is a PURE VEG. animal health care solutions company. It is a significant player in the animal feed and aquaculture sectors.[1]
- Market Cap ₹ 91.3 Cr.
- Current Price ₹ 5.30
- High / Low ₹ 10.3 / 5.21
- Stock P/E 27.1
- Book Value ₹ 5.11
- Dividend Yield 0.00 %
- ROCE 6.91 %
- ROE 5.15 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 1.04 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 70.5 to 51.6 days.
- Company's median sales growth is 27.0% of last 10 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 26.9%
- Company has a low return on equity of 4.87% over last 3 years.
- Earnings include an other income of Rs.2.07 Cr.
- Promoter holding has decreased over last 3 years: -25.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 7 | 13 | 29 | 42 | 40 | 40 | 51 | 74 | 74 | 80 | 115 | |
1 | 7 | 13 | 28 | 41 | 39 | 39 | 49 | 71 | 72 | 78 | 111 | |
Operating Profit | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 4 |
OPM % | 2% | 2% | 2% | 2% | 2% | 2% | 3% | 3% | 4% | 4% | 3% | 3% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 |
Tax % | 0% | 27% | 29% | 28% | 20% | 15% | 29% | 26% | 28% | 28% | 28% | 22% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | |
EPS in Rs | 0.02 | 0.12 | 0.18 | 0.36 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.12 | 0.20 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 32% |
5 Years: | 23% |
3 Years: | 16% |
TTM: | 43% |
Compounded Profit Growth | |
---|---|
10 Years: | 47% |
5 Years: | 56% |
3 Years: | 47% |
TTM: | 56% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | -20% |
1 Year: | -26% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 5% |
3 Years: | 5% |
Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.24 | 0.24 | 0.24 | 0.33 | 6 | 6 | 8 | 10 | 10 | 18 | 18 | 34 |
Reserves | 0 | 0 | 0 | 1 | 5 | 6 | 7 | 6 | 6 | 24 | 25 | 54 |
0 | 0 | 1 | 1 | 5 | 5 | 5 | 7 | 5 | 5 | 2 | 2 | |
0 | 1 | 1 | 11 | 4 | 1 | 2 | 6 | 7 | 12 | 3 | 5 | |
Total Liabilities | 0 | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 95 |
0 | 0 | 0 | 1 | 1 | 1 | 2 | 5 | 6 | 6 | 10 | 11 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Investments | 0 | 0 | 0 | 6 | 6 | 4 | 3 | 1 | 1 | 4 | 2 | 3 |
0 | 1 | 2 | 6 | 12 | 13 | 18 | 22 | 22 | 48 | 34 | 80 | |
Total Assets | 0 | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 95 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | -1 | -3 | -3 | -5 | -4 | 1 | 4 | -6 | -4 | -18 | ||
-0 | -0 | -2 | -0 | 1 | 0 | -3 | -2 | -16 | 8 | -17 | ||
0 | 1 | 5 | 8 | -1 | 3 | 2 | -2 | 22 | -4 | 25 | ||
Net Cash Flow | 0 | -0 | 0 | 5 | -5 | -1 | 0 | -0 | 0 | 0 | -10 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 58 | 40 | 33 | 17 | 25 | 44 | 115 | 98 | 68 | 101 | 59 | 52 |
Inventory Days | 141 | 22 | 14 | 63 | 19 | 51 | 34 | 46 | 34 | 39 | 80 | 90 |
Days Payable | 100 | 66 | 27 | 79 | 9 | 12 | 20 | 46 | 39 | 56 | 8 | 13 |
Cash Conversion Cycle | 99 | -4 | 20 | 1 | 35 | 84 | 129 | 98 | 63 | 83 | 131 | 129 |
Working Capital Days | 96 | 5 | 9 | -29 | -1 | 84 | 105 | 77 | 58 | 94 | 132 | 160 |
ROCE % | 28% | 18% | 37% | 10% | 4% | 4% | 5% | 9% | 6% | 8% | 7% |
Documents
Announcements
-
Updates
11 July 2025 - Submission of SEBI Reg 74(5) confirmation certificate for Q1 FY2025-26 dematerialization.
-
Reply to Clarification- Financial results
9 July 2025 - Ajooni Biotech submits audited FY2025 financial results with unmodified auditor's opinion and internal controls report.
-
Outcome of Board Meeting
1 July 2025 - Re-appointment of Jasjot Singh as Managing Director for 5 years from FY 2025-26, remuneration revised.
-
Trading Window-XBRL
30 June 2025 - AJOONI BIOTECH LIMITED has informed about Closure of Trading Window
-
Trading Window
30 June 2025 - Trading window closed from July 1, 2025, till 48 hours post Q1 financial results announcement.
Business Overview:[1]
ABL was incorporated in February 2010 and was promoted by Mr Jasjot Singh (chairman and managing director). It manufactures a variety of compound animal feed such as cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements. Facilities in Khanna, Punjab, have a total installed capacity of 60,000 MTPA.